ICS Opportunities II LLC 13D and 13G filings for ORIC Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-06 4:12 pm Sale | 2023-12-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | ICS Opportunities II LLC | 0 0.000% | -2,433,850 (Position Closed) | Filing |
| 2023-01-20 4:09 pm Purchase | 2023-01-13 | 13G | ORIC PHARMACEUTICALS INC ORIC | ICS Opportunities II LLC | 2,433,850 5.400% | 2,433,850 (New Position) | Filing |